Study of the Utility and Impact of Plasma <i>p</i> ‐tau181 Alzheimer's Biomarkers ‐ SUIT‐ABLE: Patient and Care Partner Outcomes

While plasma AD biomarkers provide useful information for patients and their care partners, adequate supports must be in place to address distress related to the test results.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_099787
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study of the Utility and Impact of Plasma p ‐tau181 Alzheimer's Biomarkers ‐ SUIT‐ABLE: Patient and Care Partner Outcomes

Kristin Harkins, Cameron Coykendall, Abigail Perelman, Megan Zhang et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Study of the Utility and Impact of Plasma p ‐tau181 Alzheimer's Biomarkers ‐ SUIT‐ABLE: Patient and Care Partner Outcomes

Kristin Harkins, Cameron Coykendall, Abigail Perelman, Megan Zhang, Kyra O’Brien, Jason Karlawish
article en

Abstract

While plasma AD biomarkers provide useful information for patients and their care partners, adequate supports must be in place to address distress related to the test results.

Alzheimer s & DementiaVol. 21(S2)
University of Pennsylvania (US)
Openalex Percentile: Top 34%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.